Zobrazeno 1 - 10
of 108
pro vyhledávání: '"ORHAN AYYILDIZ"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 15- (2024)
Case report: INTRODUCTION: Adrenal glands are one of the organs where malignancies frequently metastasize. However, primary malignancies of the adrenal glands are rare. Primary adrenal lymphomas (PAL) account for less than 1% of extranodal lymphomas.
Externí odkaz:
https://doaj.org/article/d5b143bb1ada4933a34ef1344c597047
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 19- (2024)
Objective: Burkitt lymphoma is an aggressive type of B-cell lymphoma that is usually seen in the pediatric and young adult population and characteised with myc gene translocation. This disease manifests itself with rapidly growing abdominal mass and
Externí odkaz:
https://doaj.org/article/7c2f7c0e93a44ed48351ac6b359e0025
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 7- (2024)
Case report: Multiple myeloma is a hematological malignancy that develops as a result of clonal proliferation of plasma cells and progresses with remissions and relapses. It is clinically characterized by many symptoms and signs such as osteolytic bo
Externí odkaz:
https://doaj.org/article/04dbcb1920ad4a30ae29eba3662a3169
Autor:
Mücahit Görük, Mehmet Sinan Dal, Tuba Dal, Abdullah Karakus, Recep Tekin, Nida Özcan, Orhan Ayyildiz
Publikováno v:
Asian Pacific Journal of Tropical Biomedicine, Vol 5, Iss 12, Pp 1051-1054 (2015)
Objective: To evaluate the febrile neutropenic patients with hematological malignancies hospitalized in hematology clinic with poor hygiene standards. Methods: A total of 124 patients with hematological malignancies (69 male, 55 female) hospitalized
Externí odkaz:
https://doaj.org/article/0f19345d359f40d58efca3c3f65c97b5
Publikováno v:
Hematology Reports, Vol 8, Iss 1 (2016)
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder characterized by intravascular hemolysis. Real-world experience of PNH management is largely unreported. A retrospective analysis was undertaken based on medical records from six p
Externí odkaz:
https://doaj.org/article/fc760858231a4e22b4fbec1975dc7e44
Publikováno v:
Volume: 14, Issue: 1 14-20
International Archives of Medical Research
International Archives of Medical Research
Amaç: Multıple myelom(MM) tanısı konulmuş olan hastaların tanı anındaki demografik özellikleri, laboratuvar parametreleri, verilen tedavileri ve tedavi yanıtları toplumlar arası farklılık göstermektedir. Multple myelom hastalarının b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115bc91ffa4152fd8a7ace2b77a712ff
https://dergipark.org.tr/tr/pub/iamr/issue/70579/1106134
https://dergipark.org.tr/tr/pub/iamr/issue/70579/1106134
Publikováno v:
International Ophthalmology. 40:3441-3451
To investigate serum levels of interleukin (IL)-12 (Th1 cytokine), IL-27 (an immunomodulatory cytokine), IL-4 (suppressor of Th1-cell growth), IL-13 (a stimulatory signal for Th2 cytokines), and IL-33 (an epithelial cell-derived cytokine) and their r
Publikováno v:
Harran Üniversitesi Tıp Fakültesi Dergisi. 16:556-561
Background: The distribution of non-Hodgkin lymphoma (NHL) subtypes differs around the world. In this study we aimed to evaluate the gender, age, subtypes, biopsy sites, nodal and extranodal residential area, and stage of disease in the patients with
Autor:
Hasan Sami Goksoy, Sevgi Kalayoglu Besisik, Zübeyde Nur Özkurt, Mehmet Sönmez, Sinem Civriz Bozdag, Irfan Yavasoglu, Tugrul Elverdi, Özgür Mehtap, Orhan Ayyildiz, Ahmet Kursad Gunes, Meliha Nalcaci, Burhan Ferhanoglu, Sebnem Izmir Guner, Meltem Kurt Yuksel, Elif Birtas Atesoglu, Selami Kocak Toprak, Tuğçe Nur Yiğenoğlu, Mustafa Pehlivan, Birol Yildiz, Ozan Salim, Rahsan Yildirim, Tayfur Toptas, Leylagül Kaynar, Ant Uzay, Murat Albayrak, Gülsüm Özet, Güray Saydam, Murat Ozbalak, Fevzi Altuntaş, İpek Yönal Hindilerden, Meltem Ayli, Olga Meltem Akay, Mehmet Hilmi Dogu
Publikováno v:
Web of Science
The AETHERA trial reported an increased progression-free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high-risk Hodgkin lymphoma (HL) after autologous stem cell transplantation (ASCT). Thus, we aimed to determine th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a7c1c4c72fda6e1343d54d2a49939b
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
Autor:
Abdullah Hacihanefioglu, Fahri Şahin, Ali Ünal, R. Yildirim, Osman Ilhan, Ozan Salim, Neslihan Andiç, Tulin Firatli Tuglular, Anil Tombak, Gülsüm Özet, Mustafa Nuri Yenerel, Zehra Özdemir, Mesude Falay, Eyup Naci Tiftik, Emin Kaya, G. Saydam, Orhan Ayyildiz, Rıdvan Ali, Mehmet Turgut, Güner Hayri Özsan, Olga Meltem Akay, Mustafa Pehlivan, Vahap Okan, Birol Guvenc, M. Sencan
Publikováno v:
Transfusion and Apheresis Science. 58:659-662
Background Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease presenting with variable and various clinical findings. PNH might be overlooked and diagnosis may be delayed due to low awareness about PNH. This is the first multicenter study in